Alison S. Long - Jan 14, 2022 Form 4 Insider Report for Kaleido Biosciences, Inc. (KLDO)

Role
Chief Medical Officer
Signature
/s/ Alison S. Long
Stock symbol
KLDO
Transactions as of
Jan 14, 2022
Transactions value $
$0
Form type
4
Date filed
1/18/2022, 04:15 PM
Previous filing
Dec 16, 2021
Next filing
Nov 3, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KLDO Restricted Stock Units Award $0 +46.8K $0.00 46.8K Jan 14, 2022 Common Stock 46.8K Direct F1, F2
transaction KLDO Restricted Stock Units Award $0 +125K $0.00 125K Jan 14, 2022 Common Stock 125K Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of the Company's common stock.
F2 The restricted stock units shall vest 100% on April 30, 2022 provided, however, that the grant shall immediately vest as of the date of any change in control of the issuer.
F3 The restricted stock units shall vest on the earlier of 50% on January 14, 2023 and 50% on January 14, 2024 provided, however, that the grant shall immediately vest as of the date of any change in control of the issuer.